Tag: Dan Starck

As the COVID-19 pandemic began to take hold in early 2020, Apria, like most other companies, had no idea what to expect, says CEO Dan Starck.  “It’s been an interesting 17 months,” he said. “We’re still observing all things related to good practice, PPE, contactless delivery. We’re contemplating bringing people back at some point, but that’s the exception right now.”  Starck spoke with HME News recently, reflecting on lessons learned...

INDIANAPOLIS – Apria Healthcare saw a healthy rebound in its oxygen and sleep business in the second quarter, and that’s where the company will focus future growth efforts, said CEO Dan Starck on a recent earnings call.  “Our new patient starts on oxygen remained elevated above historical run rates and new sleep patient volumes ran above pre-pandemic levels, while ventilation and negative pressure wound therapy were at or near pre-pandemic levels,” said Starck, who...

INDIANAPOLIS – Apria Healthcare reported net revenue of $286.3 million for the second quarter of 2021, up 6.4% compared to the same quarter in 2020.  It reported net income of $20.6 million, up 153.1%. Adjusted EBITDA was $64.4 million, up 15.5%; and adjusted EBITDA less patient equipment capex was $44.1 million, up 2.2%.  “We delivered another strong quarter as our second quarter 2021 financial results were ahead of our expectations on all three of our key metrics, achieving...

INDIANAPOLIS – Apria is readying itself for a post-COVID world by embracing flexible working arrangements and leveraging telehealth to meet patients where they are, says CEO Dan Starck. While most of its patient-facing staff and operations remained working onsite throughout the pandemic and others who had transitioned to the home are slowly moving back to the office, the company is committed to a hybrid model going forward, he says. “The pandemic challenged all of us to rapidly...

INDIANAPOLIS – Apria Healthcare reported that revenue for home respiratory therapy was up 8% in the fourth quarter of 2020, largely driven by an increase in demand for COVID-19 patients, company execs said on a recent earnings call.  New oxygen setups increased 77% during the fourth quarter of 2020, compared to the same quarter in 2019.   “The fourth quarter of 2020 was a record quarter for Apria,” said CFO Debra Morris. “While...

INDIANAPOLIS – Apria Healthcare reported net revenue of $293.8 million for the fourth quarter of 2020, an increase of 5% compared the same quarter in 2019.  Net revenue for the full year was $1.11 billion, up 2% compared to 2019.  “We made great strides during 2020, creating significant efficiencies throughout the organization, and we closed out the year with solid financial results ahead of our expectations,” said Dan Starck, CEO. “Despite the challenges presented...

WASHINGTON – CMS’s competitive bidding program set the stage for a number of the difficulties that the HME industry is seeing as it tries to meet increased demand for oxygen therapy for COVID-19 patients, say the leaders of Apria Healthcare and Lincare and the Council of Quality Respiratory Care.  The agency may have dropped oxygen from Round 2021, its latest round of bidding, but 10 years since the program’s...

LAKE FOREST, Calif. - A global pandemic wasn't exactly a consideration in the company's contingency plans, but as it celebrates its 25th anniversary, Apria Healthcare CEO Dan Starck says it has always paid to be prepared.The company began monitoring the pandemic early on and by the time the severity of it became clear in mid-March, Apria switched into high gear, increasing its inventory of PPE and moving 60% of employees to work from home in one to two weeks.“There were people who thought we...

I am writing on behalf of the Council for Quality Respiratory Care (CQRC) to highlight how our members—the home oxygen, sleep, and ventilation therapy suppliers and manufacturers-are prepared to help during the COVID-19 emergency when patients diagnosed with the disease have access to the equipment and supplies they need to recover. For us to fully serve these patients, however, we need your help in trying to address some of regulatory restriction that will be a barrier to caring for these...

WASHINGTON - Industry stakeholders are pushing providers to act fast on a bill delaying the inclusion of non-invasive ventilators in competitive bidding for five years.They'd like to get as many co-sponsors for the bill, known as the “Safeguarding Medicare Access to Respiratory Therapy (SMART) Act of 2019,” ahead of the upcoming Thanksgiving recess, and they suggest focusing first on the 180 representatives who signed a letter asking CMS to drop vents from the program.“If you are...